Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 June 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 205 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Cantwell, M. M.  [Clear All Filters]
Journal Article
C. McCourt, Coleman, H. G., Murray, L. J., Cantwell, M. M., Dolan, O., Powe, D. G., and Cardwell, C. R., Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study, Br J Dermatol, vol. 170, pp. 930-8, 2014.
C. R. Cardwell, Menamin, U. C. Mc, Hicks, B. M., Hughes, C., Cantwell, M. M., and Murray, L. J., Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts, BMC Med, vol. 12, p. 28, 2014.
M. A. O'Rorke, Murray, L. J., Hughes, C. M., Cantwell, M. M., and Cardwell, C. R., The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink, Cancer Causes Control, vol. 26, pp. 355-66, 2015.
C. R. Cardwell, Abnet, C. C., Veal, P., Hughes, C. M., Cantwell, M. M., and Murray, L. J., Exposure to oral bisphosphonates and risk of cancer, Int J Cancer, vol. 131, pp. E717-25, 2012.
C. R. Cardwell, Abnet, C. C., Cantwell, M. M., and Murray, L. J., Exposure to oral bisphosphonates and risk of esophageal cancer, Jama, vol. 304, pp. 657-63, 2010.
C. R. Cardwell, Kunzmann, A. T., Cantwell, M. M., Hughes, C., Baron, J. A., Powe, D. G., and Murray, L. J., Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort, Gastroenterology, vol. 146, pp. 700-708.e2, 2014.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., Napolitano, G., and Murray, L. J., Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study, Br J Cancer, vol. 102, pp. 1415-21, 2010.
M. C. Bradley, Murray, L. J., Cantwell, M. M., and Hughes, C. M., Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study, Br J Cancer, vol. 106, pp. 233-9, 2012.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., and Murray, L. J., Statins and pancreatic cancer risk: a nested case-control study, Cancer Causes Control, vol. 21, pp. 2093-100, 2010.
[Page last reviewed 5 June 2020]